drugset / Trial / NCT07041801
Treatment of Systemic Lupus Erythematosus With Human Umbilical Cord Mesenchymal Stem Cells
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will investigate the safety and efficacy of allogeneic umbilical cord-derived stem cell therapy in treating patients with moderate to severe systemic lupus erythematosus.
Timeline
- Start
- 2025-06-28
- Primary completion
- 2027-09-05
- Completion
- 2027-12-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | human umbilical cord mesenchymal stem cells | Cell therapy | 1e+06 cells/kg | — |
| Subject | human umbilical cord mesenchymal stem cells | Cell therapy | 3e+06 cells/kg | — |
| Subject | human umbilical cord mesenchymal stem cells | Cell therapy | 5e+06 cells/kg | — |